Fig. 3 | Scientific Reports

Fig. 3

From: 5-Fluorouracil combined with CalliSphere drug-eluting beads or conventional transarterial chemoembolization for unresectable hepatocellular carcinoma: a propensity score weighting analysis

Fig. 3

Tumor response at 1st, 3rd, and 6th month after treatment. ORR and DCR evaluating by modified Response Evaluation Criteria in Solid Tumors (mRECIST) in 5-Fu-DEB-TACE group and 5-Fu-cTACE group. The comparison of ORR and DCR at 1 month (A), 3 months (B), 6 months (C) after therapy between 5-Fu-DEB-TACE group and 5-Fu-cTACE group. CR = complete response, PR = partial response, SD = stable disease, PD = progressive disease. ORR: objective response rate, DCR: disease control rate.

Back to article page